oxybutynin and modafinil

oxybutynin has been researched along with modafinil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Du, L; Jin, Y; Li, Q; Ou, G; Wang, L; Yu, X; Zhang, S; Zhang, Y; Zhu, L; Zhu, S; Zhuang, X1

Reviews

1 review(s) available for oxybutynin and modafinil

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for oxybutynin and modafinil

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Application of armodafinil-loaded microneedle patches against the negative influence induced by sleep deprivation.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2021, Volume: 169

    Topics: Administration, Cutaneous; Animals; Cognition; Drug Delivery Systems; Drug Monitoring; Mice; Microtechnology; Modafinil; Needles; Pharmaceutic Aids; Povidone; Skin Absorption; Sleep Deprivation; Sleep Wake Disorders; Solubility; Transdermal Patch; Wakefulness-Promoting Agents

2021